Atopix Therapeutics
Pioneering new frontiers in allergy treatment with breakthrough CRTH2 antagonists.
General Information
Get notified when Atopix Therapeutics moves
Funding, new markets, leadership changes, hiring surges — one e-mail, only when something happens.
Track Atopix Therapeutics
Get real-time alerts for funding, hiring, news, and 40+ signal types.
See how it worksDiscover More
Biotechnology
About Atopix Therapeutics
Taxonomy: biopharmaceutical company, allergy treatment, CRTH2 antagonists, atopic dermatitis, asthma treatment, allergic rhinitis, clinical-stage, pharmaceutical research, innovative medicine, clinical trial, Oxford, UK, private company, European dermatology centers
Funding Rounds & Investors (4)
View All| Funding Stage | Amount | Investors | Lead Investors | Date |
|---|---|---|---|---|
| Venture Round | •••••• | 1 |
|
21 Nov 2016 |
| Debt Financing | •••••• | 1 | •••• •••• | 03 Jul 2015 |
| Series A | •••••• | 5 |
|
08 Oct 2014 |
| Grant | •••••• | 1 | •••• •••• | 30 May 2013 |
Atopix Therapeutics Alternatives & Competitors
Innovative therapies for treating androgenetic alopecia, atopic dermatitis, psoriasis, lupus erythem...
ImageneBio is a clinical-stage biotechnology company dedicated to developing therapeutics for patien...
A clinical-stage immunology focused biopharmaceutical company.
FAQ About Atopix Therapeutics
Don't just browse. Track.
Signal Tracker monitors Atopix Therapeutics and millions of companies for funding rounds, hiring surges, product changes, and 40+ signal types — so you never miss an opportunity.
